NCT02047201View on ClinicalTrials.gov

Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
RADIATION

IMRT

IMRT treatment planning using FDG-PET/CT images after induction chemotherapy (IC).

RADIATION

PET/CT

Assessing tumor response using FDG-PET/CT.

DRUG

Docetaxel

75 mg/m2, IV (in the vein) on day 1 every 3 weeks. Number of cycles: 3.

DRUG

Fluorouracil

750 mg/m2 continuous infusion for 120 h IV (in the vein) every 3 weeks. Number of cycles: 3.

DRUG

Cisplatin

75 mg/m2, IV (in the vein) on day 1 every 3 weeks. Number of cycles: 3.

Trial Locations (1)

LT-44307

Lithuanian University of Health Sciences, Kaunas

All Listed Sponsors
lead

Lithuanian University of Health Sciences

OTHER

NCT02047201 - Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC | Biotech Hunter | Biotech Hunter